drugset / Trial / NCT05429580
Prophylactic Tranexamic Acid Use After Vaginal Delivery
Completed
480 enrolled
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Sisli Hamidiye Etfal Training and Research Hospital · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
In this study, our aim was to evaluate the effectiveness of prophylactic tranexamic acid use after vaginal delivery in pregnant women aged 18-45 years and 34-42 weeks according to the risk of postpartum hemorrhage.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | — | Intravenous |
Indications
No indication recorded.